Global X Aging Population ETF Rating → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free AGNG Stock Alerts $28.47 -0.11 (-0.38%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Global X Aging Population ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy2.67Holdings in AGNG have an aggregate rating of Moderate Buy based on 415 analyst ratings issued in the past year covering 31 companies (60.4% of the portfolio).AGNG Aggregate Price Target$32.2513.26% UpsideHigh Prediction$39.22Average Prediction$32.25Low Prediction$24.84Holdings in AGNG have an aggregate price target of $32.25 and a range of $24.84 to $39.22 covering 31 companies (60.4% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 AGNG Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.12%LLYEli Lilly and Company$733.51+1.2%5 of 5 stars2.84$728.05 -0.7%19Upcoming Earnings4.04%BSXBoston Scientific$73.17-0.1%4 of 5 stars2.95$75.09 2.6%21Analyst Report3.66%WELLWelltower$94.34+0.4%3 of 5 stars2.79$95.57 1.3%14Upcoming EarningsNews CoveragePositive News3.63%DXCMDexCom$124.34-9.9%5 of 5 stars2.93$141.67 13.9%14Earnings ReportAnalyst DowngradeOptions VolumeAnalyst RevisionNews CoverageGap DownHigh Trading Volume3.59%SYKStryker$335.61-0.5%5 of 5 stars2.77$340.67 1.5%13Upcoming Earnings3.35%REGNRegeneron Pharmaceuticals$883.20-0.8%4 of 5 stars2.70$977.77 10.7%20Upcoming EarningsAnalyst ReportAnalyst RevisionNews Coverage3.26%EWEdwards Lifesciences$86.43-1.8%5 of 5 stars2.53$93.33 8.0%17Earnings ReportAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage3.24%AMGNAmgen$269.98+0.2%5 of 5 stars2.53$296.95 10.0%19Upcoming Earnings3.11%ABBVAbbVie$159.62-4.6%5 of 5 stars2.77$177.43 11.2%13Earnings ReportNews CoverageHigh Trading Volume3.04%MDTMedtronic$79.74+0.6%5 of 5 stars2.40$94.91 19.0%102.80%AZNAstraZeneca$75.17+0.2%2 of 5 stars2.50$80.00 6.4%7Analyst ReportShort Interest ↑Analyst RevisionNews Coverage2.70%JNJJohnson & Johnson$146.14-0.5%5 of 5 stars2.46$175.86 20.3%132.11%BIIBBiogen$208.90+3.2%5 of 5 stars2.67$293.88 40.7%27Earnings ReportAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage2.10%BMYBristol-Myers Squibb$44.85+0.3%5 of 5 stars2.11$60.71 35.4%19Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage1.87%ZBHZimmer Biomet$119.35-0.3%5 of 5 stars2.27$139.39 16.8%15Upcoming EarningsAnalyst RevisionNews CoveragePositive News1.21%VTRVentas$44.01+1.5%4 of 5 stars2.75$51.25 16.5%12Upcoming EarningsShort Interest ↑News Coverage1.07%BGNEBeiGene$153.58+3.4%3 of 5 stars2.80$250.13 62.9%10Upcoming EarningsAnalyst ReportShort Interest ↑Analyst RevisionNews CoverageGap Up0.92%NBIXNeurocrine Biosciences$135.99-1.3%5 of 5 stars2.74$142.38 4.7%23Upcoming EarningsAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage0.91%EXASExact Sciences$58.85+0.1%4 of 5 stars2.86$97.44 65.6%14Short Interest ↑Positive News0.87%PODDInsulet$166.19+1.2%5 of 5 stars2.80$243.21 46.3%15Positive News0.86%INCYIncyte$51.68+1.0%5 of 5 stars2.44$75.50 46.1%16Upcoming EarningsAnalyst ReportAnalyst Revision0.84%DVADaVita$133.51+0.6%4 of 5 stars2.33$118.50 -11.2%3Upcoming EarningsAnalyst UpgradeShort Interest ↓News Coverage0.77%UTHRUnited Therapeutics$233.85-0.9%5 of 5 stars2.89$294.25 25.8%9Upcoming EarningsInsider Selling0.72%TFXTeleflex$206.715 of 5 stars2.67$267.50 29.4%9Upcoming EarningsShort Interest ↓Positive News0.61%GKOSGlaukos$99.48-0.6%4 of 5 stars2.78$99.80 0.3%9Upcoming EarningsShort Interest ↓0.59%BPMCBlueprint Medicines$93.00+2.5%1 of 5 stars2.50$91.57 -1.5%14Upcoming EarningsAnalyst ReportNews CoverageGap Up0.52%EXELExelixis$23.70+0.7%5 of 5 stars2.60$26.29 10.9%15Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage0.51%OHIOmega Healthcare Investors$31.09+0.6%4 of 5 stars2.50$33.58 8.0%12Upcoming EarningsNews CoveragePositive News0.48%BKDBrookdale Senior Living$6.96+1.5%3 of 5 stars2.50$7.50 7.8%2Positive News0.47%ENSGThe Ensign Group$117.250.0%4 of 5 stars2.80$123.60 5.4%5Analyst Report0.45%ITGRInteger$109.58-1.4%1 of 5 stars2.67$120.50 10.0%6Earnings ReportAnalyst ReportShort Interest ↑News Coverage This page (NASDAQ:AGNG) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
